SCR-LIP-000220 · Claim · machine-readable JSON →

This narrative review reports genetic evidence (305 candidate genes via next-generation sequencing in 162 patients; 18 GWAS risk loci including VEGFA and GRB14-COBLL1 validated in UK Biobank; monogenic AKR1C1 and PIT1 mutations affecting progesterone and growth-hormone/prolactin pathways) supporting both hereditary and hormonal influences on lipedema onset.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
very low (GRADE)
Evidence
1 source(s)
Dates
2026-05-31 → 2026-05-31

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

2025Lipedema: Progress, Challenges, and the Road Ahead — Cifarelli (2025) · consistent

Evidence (1)

Context (PECO)

Populationwomen with lipedema (162 patients; UK Biobank cohort)
Conditionlipedema
Exposurecandidate gene variants, GWAS loci, monogenic mutations (AKR1C1, PIT1)
Outcomegenetic evidence for hereditary and hormonal lipedema onset
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log